Cellebrite Total Stockholder Equity from 2010 to 2025
| CLBT Stock | USD 19.46 0.15 0.76% |
Total Stockholder Equity | First Reported 2010-12-31 | Previous Quarter 336 M | Current Value 352.8 M | Quarterly Volatility 106.4 M |
Check Cellebrite financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellebrite's main balance sheet or income statement drivers, such as Tax Provision of 5.9 M, Interest Income of 18.8 M or Depreciation And Amortization of 8.6 M, as well as many indicators such as Price To Sales Ratio of 7.59, Dividend Yield of 0.0818 or PTB Ratio of 14.41. Cellebrite financial statements analysis is a perfect complement when working with Cellebrite Valuation or Volatility modules.
Cellebrite | Total Stockholder Equity |
Latest Cellebrite's Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of Cellebrite DI over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Cellebrite's Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellebrite's overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
Cellebrite Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 85,978,312 | |
| Coefficient Of Variation | 123.75 | |
| Mean Deviation | 64,610,547 | |
| Median | 58,828,000 | |
| Standard Deviation | 106,395,688 | |
| Sample Variance | 11320T | |
| Range | 426.2M | |
| R-Value | 0.46 | |
| Mean Square Error | 9571.5T | |
| R-Squared | 0.21 | |
| Significance | 0.07 | |
| Slope | 10,261,160 | |
| Total Sum of Squares | 169800.6T |
Cellebrite Total Stockholder Equity History
About Cellebrite Financial Statements
Cellebrite shareholders use historical fundamental indicators, such as Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Cellebrite investors may analyze each financial statement separately, they are all interrelated. The changes in Cellebrite's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellebrite's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | 336 M | 352.8 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.